Fusion Ultrasound for Diagnosis and Monitoring of Endometriosis Lesions
NCT ID: NCT04554602
Last Updated: 2024-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
24 participants
OBSERVATIONAL
2021-03-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Prevalence of Endometriosis and Adenomyosis
NCT06211569
Assessment of Performance of [18F]-FES for Endometriosis Diagnosis
NCT02233621
Use of a New Diagnostic Tool in the Detection and Characterization of Endometriosis Lesions
NCT07053982
Ultrasound Evaluation of the Pelvis in Women with Suspected Endometriosis Scheduled for Laparoscopic Surgery
NCT04171297
Evaluation of the Long-term Therapeutic Effect of High-Intensity Focused Ultrasound (HIFU) Treatment in Patients With Rectal Endometriosis
NCT07179419
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient with endometriosis or suspicion of endometriosis
* Information and collection of the non-objection before inclusion
* Interrogation, clinical examination, EHP30 and SF36 form at inclusion
* MRI, pelvic ultrasound (coupled with fusion ultrasound)
* Laparoscopy if indicated after MRI, ultrasound and fusion ultrasound
* Monitoring by form and fusion ultrasound at 6 months and then once a year for 3 years
Fusion ultrasound
Fusion ultrasound is a technique that allows a volume acquired in MRI to be coupled to an ultrasound scan with real-time image synchronisation.
Patient with other gynaecological pathology
* Information and collection of the non-opposition before inclusion
* Interrogation, clinical examination, EHP30 and SF36 form at inclusion
* MRI, pelvic ultrasound (coupled with fusion ultrasound)
* laparoscopy if indicated after MRI, ultrasound and fusion ultrasound
Fusion ultrasound
Fusion ultrasound is a technique that allows a volume acquired in MRI to be coupled to an ultrasound scan with real-time image synchronisation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fusion ultrasound
Fusion ultrasound is a technique that allows a volume acquired in MRI to be coupled to an ultrasound scan with real-time image synchronisation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient informed and who gave her non-opposition to participate in the research
* Patient with an indication for pelvic MRI and pelvic ultrasound either for the exploration of endometriosis or pelvic pain, or for another gynaecological pathology (ovarian cyst, poly-myomatous uterus, uterine malformation) outside of a proven cancer indication.
* Patient affiliated to a social security or entitled to a social security allowance
Exclusion Criteria
* Virgin patient
* Pregnant patient
* Patients under protective measures
* Contraindication to MRI (claustrophobia, intracorporeal metallic foreign body)
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Perrine CAPMAS, DR
Role: PRINCIPAL_INVESTIGATOR
APHP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AP-HP, Bicêtre Hospital
Le Kremlin-Bicêtre, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A02828-49
Identifier Type: OTHER
Identifier Source: secondary_id
APHP191069
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.